2
Clinical Trials associated with Adipose derived MSCs therapy(Ageless Regenerative Institute) / TerminatedNot Applicable An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intra- Articularly in Patients With Osteoarthritis
This will be an open-label, non-randomized, multi-center, patient sponsored study of Adipose-Derived Stromal Vascular Fraction (AD-SVF) implantation performed intra-articularly to affected joints.
The intent of this clinical study is to answer the questions: 1) Is the proposed treatment safe and 2) Is treatment effective in improving the disease pathology of patients with diagnosed Osteoarthritis.
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into the Corpus Cavernous in Patients With Erectile Dysfunction.
This will be an open-label, non-randomized, multi-center, patient sponsored study of Adipose-Derived Stromal Vascular Fraction cells (AD-SVF) implantation delivered into the corpus cavernous in patients with Erectile Dysfunction.
The intent of this clinical study is to answer the questions: 1) Is the proposed treatment safe and 2) Is treatment effective in improving the disease pathology of patients with diagnosed Erectile Dysfunction.
100 Clinical Results associated with Adipose derived MSCs therapy(Ageless Regenerative Institute)
100 Translational Medicine associated with Adipose derived MSCs therapy(Ageless Regenerative Institute)
100 Patents (Medical) associated with Adipose derived MSCs therapy(Ageless Regenerative Institute)
100 Deals associated with Adipose derived MSCs therapy(Ageless Regenerative Institute)